Animal Models of T Cell-Mediated Skin Diseases
Pharmaceutical companies are spending increasing amounts of money on drug discovery and development. Nevertheless, attrition rates in clinical development are still very high, and up to 90% of new compounds fail in clinical phase I - III trials, which is partially due to lack of clinical efficacy. T...
Συγγραφή απο Οργανισμό/Αρχή: | SpringerLink (Online service) |
---|---|
Άλλοι συγγραφείς: | Zollner, T. (Επιμελητής έκδοσης), Renz, H. (Επιμελητής έκδοσης), Asadullah, K. (Επιμελητής έκδοσης) |
Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
Γλώσσα: | English |
Έκδοση: |
Berlin, Heidelberg :
Springer Berlin Heidelberg,
2005.
|
Σειρά: | Ernst Schering Research Foundation Workshop,
50 |
Θέματα: | |
Διαθέσιμο Online: | Full Text via HEAL-Link |
Παρόμοια τεκμήρια
-
Respirology
Έκδοση: (2016) -
Clinical Management of Pulmonary Disorders and Diseases
Έκδοση: (2017) -
Advances in Respiratory Cancerogenesis
Έκδοση: (2016) -
Matrix Metalloproteinases in Tissue Remodelling and Inflammation
Έκδοση: (2008) -
A3 Adenosine Receptors from Cell Biology to Pharmacology and Therapeutics
Έκδοση: (2010)